A story in the BBC reports on the expected shift in human embryonic stem cell research policy under the incoming Obama administration. Many scientists are hopeful that he will lift the restrictive 2001 ban on certain cell lines, while others hope to see an infusion of cash and increased policy to support true bench-to-bedside research. "The impact of eight years under the previous administration for stem cell research has really been devastating," says Tom Okarma, head of stem cell company Geron.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.